Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extension safety trial of insulin degludec versus insulin detemir with insulin aspart in type 1 diabetes
2009-015721-36Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Feb 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial in diabetes mellitus type 1 (T1D) comparing Insulin degludec + insulin aspart with Insulin detemir + insulin aspart (2 arms). Started Feb 2010; status: completed.
02
Drugs
insulin degludecinsulin detemirinsulin aspart
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2009-015721-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015721-36.